About
Kamada Ltd develops plasma-derived protein therapeutics for orphan diseases using proprietary extraction and purification technology, with FDA-approved products such as Glassia for treating emphysema caused by genetic deficiency.
Explore Kamada Ltd's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.